Cargando…

Myelin Oligodendrocyte Glycoprotein (MOG(35-55)) Induced Experimental Autoimmune Encephalomyelitis (EAE) in C57BL/6 Mice

Multiple sclerosis is a chronic neuroinflammatory demyelinating disorder of the central nervous system with a strong neurodegenerative component. While the exact etiology of the disease is yet unclear, autoreactive T lymphocytes are thought to play a central role in its pathophysiology. MS therapy i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bittner, Stefan, Afzali, Ali M., Wiendl, Heinz, Meuth, Sven G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MyJove Corporation 2014
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172026/ https://www.ncbi.nlm.nih.gov/pubmed/24797125 http://dx.doi.org/10.3791/51275

Ejemplares similares

Characterization of myelin oligodendrocyte glycoprotein (MOG)(35–55)-specific CD8(+) T cells in experimental autoimmune encephalomyelitis
por: Peng, Yong, et al.
Publicado: (2019)

Arg Deficiency Does not Influence the Course of Myelin Oligodendrocyte Glycoprotein (MOG35-55)-induced Experimental Autoimmune Encephalomyelitis
por: Jacobsen, Freja Aksel, et al.
Publicado: (2016)

Myelin oligodendrocyte glycoprotein (MOG(35-55))-induced experimental autoimmune encephalomyelitis is ameliorated in interleukin-32 alpha transgenic mice
por: Yun, Jaesuk, et al.
Publicado: (2015)

Oligodendrocyte-Specific Deletion of FGFR1 Reduces Cerebellar Inflammation and Neurodegeneration in MOG(35-55)-Induced EAE
por: Rajendran, Ranjithkumar, et al.
Publicado: (2021)

Oligodendrocyte‐specific deletion of FGFR2 ameliorates MOG(35‐55)‐induced EAE through ERK and Akt signalling
por: Kamali, Salar, et al.
Publicado: (2021)

T-cell responses to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis
por: Ewing, C., et al.
Publicado: (1998)

Photobiomodulation Induced by 670 nm Light Ameliorates MOG35-55 Induced EAE in Female C57BL/6 Mice: A Role for Remediation of Nitrosative Stress
por: Muili, Kamaldeen A., et al.
Publicado: (2013)

Myelin Oligodendrocyte Glycoprotein (MOG) Optic Neuritis: A Case Series
por: Nurul-Ain, Masnon, et al.
Publicado: (2021)

Intractable Hiccup in Demyelinating Disease with Anti-Myelin Oligodendrocyte Glycoprotein (MOG) Antibody
por: Akaishi, Tetsuya, et al.
Publicado: (2016)

Gray Matter Encephalomyelitis with Anti-Myelin Oligodendrocyte Glycoprotein Antibody
por: Morizumi, Teruya, et al.
Publicado: (2020)

Anaesthetic concerns in pregnancy associated with myelin oligodendrocyte glycoprotein encephalomyelitis
por: Kuberan, Aswini, et al.
Publicado: (2022)

Rational Design and Synthesis of Altered Peptide Ligands based on Human Myelin Oligodendrocyte Glycoprotein 35–55 Epitope: Inhibition of Chronic Experimental Autoimmune Encephalomyelitis in Mice
por: Tselios, Theodore, et al.
Publicado: (2014)

The Expanding Clinical Spectrum of Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Associated Disease in Children and Adults
por: Parrotta, Erica, et al.
Publicado: (2020)

Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Positive Patients in a Multi-Ethnic Canadian Cohort
por: Cross, Helen, et al.
Publicado: (2021)

Changes in different parameters, lymphocyte proliferation and hematopoietic progenitor colony formation in EAE mice treated with myelin oligodendrocyte glycoprotein
por: Doronin, Vasilii B., et al.
Publicado: (2015)

Passive Experimental Autoimmune Encephalomyelitis in C57BL/6 with MOG: Evidence of Involvement of B Cells
por: Mannara, Francesco, et al.
Publicado: (2012)

Myelin Oligodendrocyte Glycoprotein (MOG)-IgG Associated Demyelinating Disease: Our Experience with this Distinct Syndrome
por: Pujari, Shripad S., et al.
Publicado: (2021)

Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Disease in a 11 Year Old with COVID-19 Infection
por: Khan, Archana, et al.
Publicado: (2021)

Acute disseminated encephalomyelitis associated with anti-myelin oligodendrocyte glycoprotein (MOG-IGG) antibody in a patient with recent vaccination against SARS-CoV-2
por: Simone, Anna Maria, et al.
Publicado: (2021)

Damage to the Optic Chiasm in Myelin Oligodendrocyte Glycoprotein–Experimental Autoimmune Encephalomyelitis Mice
por: Herrera, Sheryl L, et al.
Publicado: (2014)

Astrocytoma with myelin oligodendrocyte glycoprotein antibody associated encephalomyelitis: A case report
por: Zhong, Guanghong, et al.
Publicado: (2022)

The Postpartum Period Can Worsen Myelin Oligodendrocyte Glycoprotein Antibody-associated Encephalomyelitis
por: Yamamoto, Shizuka, et al.
Publicado: (2022)

Oral Tolerance Induction in Experimental Autoimmune Encephalomyelitis with Candida utilis Expressing the Immunogenic MOG35-55 Peptide
por: Buerth, Christoph, et al.
Publicado: (2016)

Impaired Brain Growth in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Acute Disseminated Encephalomyelitis
por: Bartels, Frederik, et al.
Publicado: (2023)

Pattern Visually Evoked Potentials in Japanese Girl With Optic Neuritis and Seropositive to Anti-myelin Oligodendrocyte Glycoprotein (MOG) Antibody
por: Takano, Shunichiro, et al.
Publicado: (2019)

Bilateral Acute Optic Perineuritis Associated With COVID-19 in a Patient With Seronegative Myelin Oligodendrocyte Glycoprotein (MOG) Antibody
por: Ali, Liaquat, et al.
Publicado: (2021)

Soluble MOG35-55/I-A(b) Dimers Ameliorate Experimental Autoimmune Encephalomyelitis by Reducing Encephalitogenic T Cells
por: Gong, Yeli, et al.
Publicado: (2012)

A case of anti-myelin oligodendrocyte glycoprotein (MOG)-immunoglobulin G (IgG) associated disorder (MOGAD) with clinical manifestations of acute disseminated encephalomyelitis: Secondary to mycoplasma pneumoniae infection
por: Huang, Xiangui, et al.
Publicado: (2023)

Seizure and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Encephalomyelitis in a Retrospective Cohort of Chinese Patients
por: Zhong, Xiaonan, et al.
Publicado: (2019)

Clinical and Neuroimaging Characteristics of Pediatric Acute Disseminating Encephalomyelitis With and Without Antibodies to Myelin Oligodendrocyte Glycoprotein
por: Zhang, Min, et al.
Publicado: (2020)

Tozinameran: Anti-myelin oligodendrocyte glycoprotein antibody-positive acute disseminated encephalomyelitis: case report
Publicado: (2022)

Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Diseases in Children in Central South China: Clinical Features, Treatments, Influencing Factors, and Outcomes
por: Mao, Leilei, et al.
Publicado: (2019)

Combined Central and Peripheral Demyelination in a Patient of Multifocal Motor Neuropathy and Positive Anti-myelin Oligodendrocyte Glycoprotein (MOG) Antibodies
por: Elterefi, Alanood E, et al.
Publicado: (2022)

Copaiba Oil Suppresses Inflammatory Cytokines in Splenocytes of C57Bl/6 Mice Induced with Experimental Autoimmune Encephalomyelitis (EAE)
por: Dias, Débora S., et al.
Publicado: (2014)

Immune profile of an atypical EAE model in marmoset monkeys immunized with recombinant human myelin oligodendrocyte glycoprotein in incomplete Freund’s adjuvant
por: Jagessar, S. Anwar, et al.
Publicado: (2015)

The Extracellular Domain of Myelin Oligodendrocyte Glycoprotein Elicits Atypical Experimental Autoimmune Encephalomyelitis in Rat and Macaque Species
por: Curtis, Alan D., et al.
Publicado: (2014)

A Case of Anti-Myelin Oligodendrocyte Glycoprotein Antibody-Positive Late-Onset Acute Disseminated Encephalomyelitis
por: Kim, Ki Hoon, et al.
Publicado: (2021)

Evaluation of diagnostic criteria and red flags of myelin oligodendrocyte glycoprotein encephalomyelitis in a clinical routine cohort
por: Veselaj, Krenar, et al.
Publicado: (2020)

Active induction of experimental autoimmune encephalomyelitis by MOG(35-55) peptide immunization is associated with differential responses in separate compartments of the choroid plexus
por: Murugesan, Nivetha, et al.
Publicado: (2012)

Pathophysiology of myelin oligodendrocyte glycoprotein antibody disease
por: Corbali, Osman, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8k54v1t9338kkqgbb9v85ed72v